Replimune Group, Inc. (REPL)

Replimune Group Statistics

Total Valuation

Replimune Group has a market cap or net worth of $736.58 million. The enterprise value is $489.26 million.

Market Cap	736.58M
Enterprise Value	489.26M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Replimune Group has 78.44 million shares outstanding. The number of shares has increased by 27.30% in one year.

Current Share Class	78.44M
Shares Outstanding	78.44M
Shares Change (YoY)	+27.30%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	5.11%
Owned by Institutions (%)	78.48%
Float	52.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.80
P/TBV Ratio	2.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.29.

Current Ratio	6.31
Quick Ratio	6.15
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-39.96

Financial Efficiency

Return on equity (ROE) is -96.24% and return on invested capital (ROIC) is -49.91%.

Return on Equity (ROE)	-96.24%
Return on Assets (ROA)	-44.83%
Return on Invested Capital (ROIC)	-49.91%
Return on Capital Employed (ROCE)	-94.59%
Revenue Per Employee	n/a
Profits Per Employee	-$647,731
Employee Count	479
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Replimune Group has paid $468,000 in taxes.

Income Tax	468,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.11% in the last 52 weeks. The beta is 0.67, so Replimune Group's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-37.11%
50-Day Moving Average	6.83
200-Day Moving Average	8.36
Relative Strength Index (RSI)	63.80
Average Volume (20 Days)	2,562,358

Short Selling Information

The latest short interest is 16.10 million, so 20.53% of the outstanding shares have been sold short.

Short Interest	16.10M
Short Previous Month	18.25M
Short % of Shares Out	20.53%
Short % of Float	30.48%
Short Ratio (days to cover)	2.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-318.34M
Pretax Income	-309.80M
Net Income	-310.26M
EBITDA	-312.95M
EBIT	-318.34M
Earnings Per Share (EPS)	-$3.47

Balance Sheet

The company has $323.64 million in cash and $76.32 million in debt, giving a net cash position of $247.32 million or $3.15 per share.

Cash & Cash Equivalents	323.64M
Total Debt	76.32M
Net Cash	247.32M
Net Cash Per Share	$3.15
Equity (Book Value)	263.34M
Book Value Per Share	3.36
Working Capital	280.85M

Cash Flow

In the last 12 months, operating cash flow was -$262.67 million and capital expenditures -$7.02 million, giving a free cash flow of -$269.69 million.

Operating Cash Flow	-262.67M
Capital Expenditures	-7.02M
Free Cash Flow	-269.69M
FCF Per Share	-$3.44

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Replimune Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.30%
Shareholder Yield	-27.30%
Earnings Yield	-42.12%
FCF Yield	-36.61%

Analyst Forecast

The average price target for Replimune Group is $12.00, which is 27.80% higher than the current price. The consensus rating is "Buy".

Price Target	$12.00
Price Target Difference	27.80%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1